<DOC>
	<DOC>NCT01443585</DOC>
	<brief_summary>The purpose of the trial is to clinically evaluate the performance of a progressive addition lens among presbyopic patients. This evaluation will be done by performing visual tests and collecting subjective information from subjects wearing the lens which will be manufactured according to personal prescription.</brief_summary>
	<brief_title>Clinical Evaluation of a Progressive Addition Lens (PAL)</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<criteria>An ability to comprehend and give an informed consent for participation in the trial Presbyopia Concurrent participation in another clinical trial Age&lt;18 For female subjects: pregnancy \ planning a pregnancy \ lactating at the time of enrollment Imbalanced diabetes \ high blood pressure \ thyroid disease Infectious disease Inability (cognitively) to comprehend the instructions given during the trial and to comply with them</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Progressive Addition Lens</keyword>
	<keyword>Multifocal</keyword>
	<keyword>Presbyopia</keyword>
</DOC>